ABSTRACT
Background: Urolithiasis during pregnancy poses unique challenges due to concerns regarding maternal and fetal safety. Ureteroscopy (URS) with internal ureteral stent (IUS) placement has emerged as a potential management strategy. However, comprehensive assessment of its safety, efficacy, and impact on maternal-fetal outcomes is warranted.
Aim: This study aimed to evaluate the safety, efficacy, and maternal-fetal outcomes associated with URS and IUS placement for managing urolithiasis during pregnancy.
Methods: A retrospective analysis was conducted on 120 pregnant women with urolithiasis who underwent URS and IUS placement at Mayo Hospital, Lahore, between April 2022 and December 2023. Data on procedural complications, stone clearance rates, maternal complications, fetal outcomes, and delivery details were collected and analyzed.
Results: The study population comprised 120 pregnant women with urolithiasis who underwent URS and IUS placement. The procedural success rate was 95%, with complete stone clearance achieved in 90% of cases. Maternal complications were observed in 15% of patients, predominantly consisting of urinary tract infections and transient hematuria. Fetal outcomes remained favorable, with no instances of fetal distress or preterm labor attributed to the procedure. Delivery occurred at term in 80% of cases, with the remaining 20% requiring elective preterm delivery due to non-procedural reasons.
Conclusion: Ureteroscopy with internal ureteral stent placement appears to be a safe and effective option for managing urolithiasis during pregnancy, with favorable maternal and fetal outcomes. This minimally invasive approach offers high stone clearance rates while minimizing risks to both mother and fetus. However, careful patient selection and close monitoring are essential to mitigate potential complications.
Keywords: Urolithiasis, Pregnancy, Ureteroscopy, Internal ureteral stent, Maternal-fetal outcomes, Safety, Efficacy, Mayo Hospital, Lahore.